ALLE
44
5
GE
61
4
AKAM
54
3
BF.B
31
2
FDX
41
11
LRCX
48
6
RSG
62
2
RF
54
3
DIS
52
3
DOV
61
4
HUM
39
9
HCP
54
7
UNH
55
5
NTRS
54
4
CNX
75
6
PFE
21
-2
OI
34
6
BK
69
4
SLB
45
4
CPB
30
5
ALLE
44
5
GE
61
4
AKAM
54
3
BF.B
31
2
FDX
41
11
LRCX
48
6
RSG
62
2
RF
54
3
DIS
52
3
DOV
61
4
HUM
39
9
HCP
54
7
UNH
55
5
NTRS
54
4
CNX
75
6
PFE
21
-2
OI
34
6
BK
69
4
SLB
45
4
CPB
30
5
Financhill
Back

Cytokinetics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
49

CYTK
Cytokinetics

Last Price:
55.63
Seasonality Move:
12.68%
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
273.01
Seasonality Move:
13.19%
Sell
49
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $52.52. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $265.29. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $52.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $265.29
    The current trend is relatively stagnant and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 47.02 Sell
Chaikin Money Flow: 625350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.87 - 55.13) Sell
Bollinger Bands (100): (52.82 - 56.94) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 38.35 Sell
Chaikin Money Flow: -512521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (269.84 - 291.34) Sell
Bollinger Bands (100): (228.29 - 288.29) Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.67 Buy
20-day SMA: 53.22 Sell
50-day SMA: 54.14 Sell
200-day SMA: 61.3 Sell
8-day EMA: 52.06 Buy
20-day EMA: 52.83 Sell
50-day EMA: 53.92 Sell
200-day EMA: 55.59 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 276.73 Sell
20-day SMA: 283.15 Sell
50-day SMA: 274.11 Sell
200-day SMA: 206.52 Buy
8-day EMA: 275.27 Sell
20-day EMA: 279.04 Sell
50-day EMA: 272.53 Sell
200-day EMA: 227.54 Buy

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):